Gene: RAP2C
Official Full Name: RAP2C, member of RAS oncogene familyprovided by HGNC
Gene Summary: The protein encoded by this gene is a member of the Ras-related protein subfamily of the Ras GTPase superfamily. Members of this family are small GTPases that act as molecular switches to regulate cellular proliferation, differentiation, and apoptosis. This protein has been reported to activate in vitro transcriptional activity of the serum response element. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14709 | RAP2C Knockout cell line (HeLa) | Human | RAP2C | 1:3~1:6 | Negative | Online Inquiry |
KO14710 | RAP2C Knockout cell line (HCT 116) | Human | RAP2C | 1:2~1:4 | Negative | Online Inquiry |
KO14711 | RAP2C Knockout cell line (HEK293) | Human | RAP2C | 1:3~1:6 | Negative | Online Inquiry |
KO14712 | RAP2C Knockout cell line (A549) | Human | RAP2C | 1:3~1:4 | Negative | Online Inquiry |
RAP2C Gene Knockout Cell Lines are specially engineered cellular models that lack the expression of the RAP2C gene, a member of the RAS oncogene family involved in various cellular processes, including signal transduction and cellular growth. These cell lines are generated using advanced CRISPR-Cas9 genome editing techniques, ensuring precise alterations at the genomic level, which allow researchers to dissect the biological roles of RAP2C in both normal physiology and disease states.
The primary function of RAP2C is to regulate multiple pathways associated with cell growth, differentiation, and survival. By creating knockout models, scientists can explore the consequential impacts of RAP2C deficiency on signaling cascades, enabling detailed investigations into its role in cancer biology, neurodevelopmental disorders, and other pathophysiological conditions. Such studies may contribute significantly to the understanding of tumorigenesis and potential therapeutic targets.
In the context of research or clinical settings, RAP2C Gene Knockout Cell Lines serve as invaluable tools for drug discovery and development, particularly in screening for compounds that can modulate pathways altered by RAP2C. The specificity of these cell lines provides researchers with a robust platform to evaluate the efficacy and mechanism of action of novel therapeutics in vitro.
What sets RAP2C Gene Knockout Cell Lines apart from conventional cell models is their precision and functional relevance. Many existing cell lines may express varying levels of RAP2C, affecting the reproducibility and reliability of experimental outcomes. In contrast, our knockout lines offer a consistent, controlled environment for studying the absence of RAP2C, thus enhancing the validity of experimental data.
These cell lines are indispensable for researchers and clinicians aiming to unravel complex cellular mechanisms, develop targeted therapies, or validate hypotheses regarding the role of RAP2C in disease. Investing in RAP2C Gene Knockout Cell Lines implies access to cutting-edge technology and resources that can significantly advance scientific inquiry and foster innovations in healthcare.
Our company prides itself on its commitment to advancing biological research through quality products and expert support. With a focus on precision and reliability, we provide tools that empower the scientific community to explore the intricacies of gene function and develop impactful solutions in medicine and industry.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.